High plasma levels of both PAI-1 and the urokinase receptor have been shown to correlate with a negative prognosis for cancer patients.
Os niveis altos en plasma de PAI-1 e de receptor da uroquinase correlaciónanse cun prognóstico desfavorable para pacientes de cancro.